When the Berlin Patient was cured of AIDS, it provided the clinical proof that AIDS can be cured, something that was unthinkable until then. This success has not yet been translated into a broadly-accessible cure for all HIV/AIDS patients. Chromovert© Technology is a cutting-edge biotechnology that holds promise as the missing link to reach this goal. Invented at the Rockefeller University in New York City, Chromovert is pioneered by the life science company spun out of that laboratory, Chromocell Corporation.
A collaborative approach is needed to accelerate the development of a truly accessible cure for AIDS. To this end, the Research Foundation to Cure AIDS has been established to create the leading alliance of the critical laboratories, medical teams and core technologies. By aligning research, development, clinical and roll-out strategies, the Foundation’s mission is to develop the cure for AIDS and to make it accessible and affordable to those in need worldwide. www.RFTCA.org
The Research Foundation to Cure AIDS presents:
The Road to the Cure Symposium
The science for a broadly applicable cure for AIDS is on the horizon.
The Research Foundation to Cure AIDS has been expressly created to build an unprecedented alliance of the critical stakeholders and core technologies needed to achieve this ambitious goal. This is a radical and differentiated initiative about actually curing AIDS, and not about prevention or treatment.
Please join us to explore the opportunity, challenges and impact of a world without AIDS. The story will unfold in three chapters:
1) The science of a stem cell cure to AIDS - the Berlin Patient case study
2) The challenges to end the HIV/AIDS epidemic in NYC and worldwide
3) The global socioeconomic impact of a world without AIDS
3:00 - 5:00 p.m.
Reception to follow.
Symposium Participants and Speakers
Timothy Ray Brown - The Berlin Patient, Editor, Cure Report, co-Founder, Cure for AIDS Coalition and World AIDS Institute
Demetre Daskalakis, M.D., M.P.H. - Assistant Commissioner NYC DOHMH, Bureau of HIV Prevention and Control
Maria Gotsch, M.B.A - President and CEO at the Partnership Fund for New York City
Scott Hammer, M.D.S - Chief, Division of Infectious Diseases, Columbia University, College of Physicians & Surgeon
Ali Hemmati-Brivanlou, Ph.D. - Robert and Harriet Heilbrunn Professor, Rockefeller University, Director, Tri-Inst. Human Embryonic Stem Cell Derivation Unit
David Purdy - Editor, Cure Report, co-Founder, Cure for AIDS Coalition and World AIDS Institute
Kambiz Shekdar, Ph.D. - President, Research Foundation to Cure AIDS, co-Founder and former Chief Scientific Officer, Chromocell Corporation
Milton Wainberg, M.D. - Medical Director of the Columbia University HIV Mental Health Training Project of the NY/NJ